• Project
    • Overview
    • Research >
      • Work Packages
      • Individual Research Projects
    • Governance
  • Network
    • Beneficiaries
    • Partner Organisations
  • People
    • Supervisors >
      • Theodora Calogeropoulou
      • Rebecca Wade
      • Stefano Mangani
      • Christophe Rochais
      • Vasileios Roussis
      • Vasileia Ismini Alexaki
      • Achilleas Gravanis
      • Ka Wan Li
      • Dame Pamela Shaw
    • Early Stage Researchers >
      • ESR1: Daniele Narducci
      • ESR2: Alessia Latorrata
      • ESR3: Athanasios-Alexandros Tsengenes
      • ESR4: Christina Athanasiou
      • ESR5: Federica Carucci
      • ESR6: Mirjana Antonijević
      • ESR7: Paolo Giaccio
      • ESR8: Canelif Yilmaz
      • ESR9: Ana Aragón
      • ESR10: Débora Pita
      • ESR11: Thanasis Rogdakis
      • ESR12: Desponia Charou
      • ESR13: Evangelia Thanou
      • ESR14: Marco Destro
    • Scientific Advisory Board
  • Training
    • Approach
    • Objectives >
      • Secondments
    • Events >
      • 1st Network Week
      • 2nd Network Week
      • 3rd Network Week
  • Publications
  • Outreach
    • Events
    • Public Engagement
    • Results
    • Conference
    • Newsletter >
      • January 2021
      • April 2021
      • December 2021
  • News
  • Job Openings
    • Vacancies
    • Submit your application
  • Contact
EURONEUROTROPHIN
  • Project
    • Overview
    • Research >
      • Work Packages
      • Individual Research Projects
    • Governance
  • Network
    • Beneficiaries
    • Partner Organisations
  • People
    • Supervisors >
      • Theodora Calogeropoulou
      • Rebecca Wade
      • Stefano Mangani
      • Christophe Rochais
      • Vasileios Roussis
      • Vasileia Ismini Alexaki
      • Achilleas Gravanis
      • Ka Wan Li
      • Dame Pamela Shaw
    • Early Stage Researchers >
      • ESR1: Daniele Narducci
      • ESR2: Alessia Latorrata
      • ESR3: Athanasios-Alexandros Tsengenes
      • ESR4: Christina Athanasiou
      • ESR5: Federica Carucci
      • ESR6: Mirjana Antonijević
      • ESR7: Paolo Giaccio
      • ESR8: Canelif Yilmaz
      • ESR9: Ana Aragón
      • ESR10: Débora Pita
      • ESR11: Thanasis Rogdakis
      • ESR12: Desponia Charou
      • ESR13: Evangelia Thanou
      • ESR14: Marco Destro
    • Scientific Advisory Board
  • Training
    • Approach
    • Objectives >
      • Secondments
    • Events >
      • 1st Network Week
      • 2nd Network Week
      • 3rd Network Week
  • Publications
  • Outreach
    • Events
    • Public Engagement
    • Results
    • Conference
    • Newsletter >
      • January 2021
      • April 2021
      • December 2021
  • News
  • Job Openings
    • Vacancies
    • Submit your application
  • Contact

Positions Description

ESR1: Synthesis of dehydroepiandrosterone (DHEA) derivatives substituted by five or six membered-17-spiro substituents
  • Host Institution: National Hellenic Research Foundation (NHRF), Athens, Greece
  • Contract Duration: 12 Months renewable up to 36 months
  • Start Date: 1st September 2018
  • Planned secondments: Peakdale Molecular, United Kingdom (3 months), UNISI, Italy (2 months)

ESR2: Synthesis of dehydroepiandrosterone (DHEA) derivatives substituted by three membered-17-spiro substituents
  • Host Institution: National Hellenic Research Foundation (NHRF), Athens, Greece
  • Contract Duration: 12 Months renewable up to 36 months
  • Start Date: 1st September 2018
  • Planned secondments: HITS, Germany (1 month), TUD, Germany (2 months), VUA, The Netherlands (2 months)

ESR3: Computer-aided molecular design
  • Host Institution: Heidelberg Institute for Theoretical Studies (HITS), Heidelberg, Germany
  • Contract Duration: 12 Months renewable up to 36 months
  • Start Date: 1st September 2018
  • Planned secondments: UNICAEN, France (2 months), UNISI, Italy (2 months), NKUA, Greece (1 month)

ESR4: Modelling of mechanistic effects of neurotrophin modulators
  • Host Institution: Heidelberg Institute for Theoretical Studies (HITS), Heidelberg, Germany
  • Contract Duration: 12 Months renewable up to 36 months
  • Start Date: 1st September 2018
  • Planned secondments: UNISI, Italy (2 months), NHRF, Greece (1 month), TUD, Germany (2 months)

ESR5: Production of purified protein targets and x-ray crystal structure determination of target-ligand complexes
  • Host Institution: University of Siena (UNISI), Siena, Italy
  • Contract Duration: 12 Months renewable up to 36 months
  • Start Date: 1st September 2018
  • Planned secondments: Novartis (Hellas) S.A.C.I., Greece (2 months), FORTH, Greece (1 month), USFD, United Kingdom (2 months)
 
ESR6: In silico screening and Hit to lead development of small molecules neurotrophin receptors ligands
  • Host Institution: Universite de Caen Normandie (UNICAEN), Caen, France
  • Contract Duration: 12 Months renewable up to 36 months
  • Start Date: 1st September 2018
  • Planned secondments: UoC, Greece (1 month), Innoprot, Spain (3 months), NHRF, Greece (1 month)
 
ESR7: Isolation of new natural neurotrophin mimetics from marine microorganisms
  • Host Institution: National and Kapodistrian University of Athens (NKUA), Athens, Greece
  • Contract Duration: 12 Months renewable up to 36 months
  • Start Date: 1st September 2018
  • Planned secondments: USFD, United Kingdom (2 months), UoC, Greece (2 months), HITS, Germany (2 months)

ESR8: Evaluation of small molecule neurotrophin mimetics in models of neurodegeneration and neuroinflammation
  • Host Institution: Technische Universitat Dresden (TUD), Dresden, Germany
  • Contract Duration: 12 Months renewable up to 36 months
  • Start Date: 1st September 2018
  • Planned secondments: ACS, United Kingdom (1 month), FORTH, Greece (2 months), UNICAEN, France (2 months)

ESR9: Development of Human Cell-Based Models for study of Blood Brain Barrier Molecular Permeability
  • Host Institution: AvantiCell Science Ltd (ACS), Scotland, UK
  • Contract Duration: 12 Months renewable up to 26 months
  • Start Date: 1st September 2019
  • Planned secondments: NKUA, Greece (2 months), UNISI, Italy (2 months)

ESR10: Development of Human Cell-Based Models for Neurotrophic Therapeutic Testing
  • Host Institution: AvantiCell Science Ltd (ACS), Scotland, UK
  • Contract Duration: 12 Months renewable up to 26 months
  • Start Date: 1st September 2019
  • Planned secondments: VUA, The Netherlands (2 months), FORTH, Greece (2 months)
 
ESR11: Evaluation of activity on neurotrophin receptors and their role in signaling, in in vitro and in vivo neurodegenerative conditions, such as AD
  • Host Institution: Foundation for Research and Technology Hellas (FORTH), Heraklion, Greece
  • Contract Duration: 12 Months renewable up to 36 months
  • Start Date: 1st September 2018
  • Planned secondments: UNISI, Italy (2 months), ACS, United Kingdom (1 month), VUA, The Netherlands (2 months)

ESR12: In vitro and in vivo effects of new synthetic and natural compounds on Neural Stem Cells and adult neurogenesis in AD
  • Host Institution: Foundation for Research and Technology Hellas (FORTH), Heraklion, Greece
  • Contract Duration: 12 Months renewable up to 36 months
  • Start Date: 1st September 2018
  • Planned secondments: TUD, Germany (2 months), Innoprot, Spain (3 months)
 
ESR13: Investigation of the potency of small molecule mimetics of neurotrophins to rescue the reduction in synapse number and the aberrant synapse proteome in mouse models of AD
  • Host Institution: VU University of Amsterdam (VUA), Amsterdam, Netherlands
  • Contract Duration: 12 Months renewable up to 36 months
  • Start Date: 1st December 2018
  • Planned secondments: FORTH, Greece (2 months), TUD, Germany (2 months), Novartis (Hellas) S.A.C.I., Greece (2 months)

ESR14: The neuroprotective effects of neurotrophins in novel in vitro and in vivo models of Motor Neurone Disease (ALS/MND)
  • Host Institution: University of Sheffield (USFD), Sheffield, United Kingdom
  • Contract Duration: 12 Months renewable up to 36 months
  • Start Date: 1st October 2018
  • Planned secondments: NKUA, Greece (2 months), TUD, Germany (2 months), HITS, Germany (2 months) 
Picture

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 765704
Disclaimer | Member Area
© accelopment Schweiz 2019. ALL RIGHTS RESERVED.
  • Project
    • Overview
    • Research >
      • Work Packages
      • Individual Research Projects
    • Governance
  • Network
    • Beneficiaries
    • Partner Organisations
  • People
    • Supervisors >
      • Theodora Calogeropoulou
      • Rebecca Wade
      • Stefano Mangani
      • Christophe Rochais
      • Vasileios Roussis
      • Vasileia Ismini Alexaki
      • Achilleas Gravanis
      • Ka Wan Li
      • Dame Pamela Shaw
    • Early Stage Researchers >
      • ESR1: Daniele Narducci
      • ESR2: Alessia Latorrata
      • ESR3: Athanasios-Alexandros Tsengenes
      • ESR4: Christina Athanasiou
      • ESR5: Federica Carucci
      • ESR6: Mirjana Antonijević
      • ESR7: Paolo Giaccio
      • ESR8: Canelif Yilmaz
      • ESR9: Ana Aragón
      • ESR10: Débora Pita
      • ESR11: Thanasis Rogdakis
      • ESR12: Desponia Charou
      • ESR13: Evangelia Thanou
      • ESR14: Marco Destro
    • Scientific Advisory Board
  • Training
    • Approach
    • Objectives >
      • Secondments
    • Events >
      • 1st Network Week
      • 2nd Network Week
      • 3rd Network Week
  • Publications
  • Outreach
    • Events
    • Public Engagement
    • Results
    • Conference
    • Newsletter >
      • January 2021
      • April 2021
      • December 2021
  • News
  • Job Openings
    • Vacancies
    • Submit your application
  • Contact